#Tianjin #Tianjin Pharmaceutical Research Institute National Industrial Technology Platform Project successfully passed the acceptance, and the laboratory construction project of the International Drug Research and Development Center is about to start! Recently, the national industrial technology service platform project led by Tianjin Pharmaceutical Research Institute - "Industrial Technology Basic Public Service Platform for the Pharmaceutical Industry" successfully passed the on-site acceptance organized by relevant departments. At the same time, the company plans to invest 72.56 million yuan to build a laboratory construction project of an international drug research and development center. It is reported that the Tianjin Pharmaceutical Research Institute is located in the Bolonghu Science and Technology Park of Tianjin Binhai High-tech Zone, and has an expert team led by academicians of the Chinese Academy of Engineering, covering drug synthesis, new drugs of traditional Chinese medicine, pharmaceutical preparations, drug analysis, drug evaluation, pharmaceutical information and other fields. With more than 60 years of experience in new drug research and development, he has completed more than 200 major scientific research projects at the national, provincial and ministerial levels, achieved more than 700 scientific research achievements, obtained more than 300 new drug certificates, clinical approvals or production approvals, won more than 300 awards at the international and domestic levels, and has nearly 500 authorized patents, many of which have won the China Patent Excellence Award and the Tianjin Patent Gold Award. Since the successful mixed reform of China Merchants Group in 2018, Tianjin Pharmaceutical Research Institute has continued to strengthen and maintain its scientific research capabilities while further combining with market demand and extending to the downstream direction of the industrial chain such as application transformation.
